* Meta-terms correspond to biological or medical specialty concerned
with one or more keywords (or keywords hierarchies), qualifiers, or resource types.
Other terms also benefit from this structure, when the topic warrants it, eg education.
See the list.
Preferred Label : dermatology;
True Meta (CISMeF) : O;
Origin ID : MT10;
UMLS CUI : C0011627;
ATC codes
Automatic exact mappings (from CISMeF team)
CISMeF Querying Strategi(ies)
CISMeF manual mappings
ICD-10 codes
- Acne [ICD-10 category (who)]
- Pallor [ICD-10 Sub-category (who)]
ICD-11 codes
Indication(s)
MeSH
SNOMED CT concepts
SNOMED int. notions
See also
Semantic type(s)
UMLS correspondences (same concept)
Validated automatic mappings to BTNT
https://www.reiso.org/articles/themes/pratiques/13536-des-presences-actives-recette-du-vivre-ensemble
2025
Switzerland
journal article
activir
recipes
activator appliances
---
http://www.orpha.net/data/patho/Emg/Int/fr/Sclerodermie_FR_fr_EMG_ORPHA801.pdf
2025
false
false
false
France
French
scientific and technical information
emergency medicine
scleroderma, systemic
scleroderma, systemic
---
https://www.has-sante.fr/jcms/p_3576108/fr/adzynma-apadamtase-alfa-purpura-thrombotique-thrombocytopenique-congenital-pttc-pediatrie
2025
false
false
false
France
child
treatment outcome
insurance, health, reimbursement
Apadamtase Alfa
guidelines for drug use
apadamtase alfa and cinaxadamtase alfa
Cinaxadamtase Alfa
enzyme replacement therapy
ADAMTS13 protein, human
injections, intravenous
evaluation of the transparency committee
purpura, thrombotic thrombocytopenic
congenital thrombotic thrombocytopenic purpura
---
https://www.has-sante.fr/jcms/p_3586231/fr/adzynma-adamts13r-purpura-thrombotique-thrombocytopenique-congenital-pttc
2025
false
false
false
France
ADAMTS13 Protein
Apadamtase Alfa
enzyme replacement therapy
congenital thrombotic thrombocytopenic purpura
adult
child
treatment outcome
insurance, health, reimbursement
orphan drug production
injections, intravenous
Congenital thrombotic thrombocytopenic purpura
evaluation of the transparency committee
purpura, thrombotic thrombocytopenic
---
https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/les-casques-refrigerants-efficacite-et-innocuite-pour-prevenir-lalopecie-induite-par-la-chimiotherapie.html
2025
Canada
health technology assessment
efficiency
alopecia, nos
helmets
chemotherapy, nos
attentiveness
head protective devices
alopecia
refrigeration
refrigerator
chemotherapy
---
https://cngof.fr/app/pdf/RPC//RPC%20DU%20CNGOF/Gyn%C3%A9cologie/Oncologie/Reco%20depistage%20col%20GOFS%202025.pdf?x60010
2025
France
consensus
dermatomyositis
screening
health planning guidelines
disease management
women
uterus, nos
viral disease other/nos
papillomaviridae
cell biology
Cytology
female
abnormal behavior, nos
mass screening
---
https://www.cochrane.org/fr/CD013614/CENTRALED_quels-sont-les-benefices-et-risques-des-inhibiteurs-du-tnf-chez-les-personnes-atteintes-de
2025
United Kingdom
review of literature
french abstract
psoriasis, nos
arthritis
disease
risk assessment
polyarthritis
Polyarthritis
psoriasis
risks and benefits
tumor necrosis factor
persons
Tumor Necrosis Factor Inhibitors
anti-TNF
---
https://www.has-sante.fr/jcms/p_3594961/fr/spevigo-spesolimab-psoriasis-pustuleux-generalise-ppg-chez-l-adulte-et-l-adolescent
2025
false
false
false
France
treatment outcome
insurance, health, reimbursement
injections, subcutaneous
spesolimab
Generalized pustular psoriasis
Generalized pustular psoriasis flare
evaluation of the transparency committee
adolescent
spesolimab
adult
psoriasis
---
https://www.has-sante.fr/jcms/p_3598324/fr/otezla-apremilast-psoriasis-en-plaques-modere-a-severe-chez-les-enfants-et-adolescents-a-partir-de-6-ans
2025
false
false
false
France
treatment outcome
insurance, health, reimbursement
apremilast
administration, oral
evaluation of the transparency committee
child
psoriasis
apremilast
adolescent
---
https://www.has-sante.fr/jcms/p_3598812/fr/nordimet-methotrexate-psoriasis-en-plaque-modere
2025
false
false
false
France
adult
insurance, health, reimbursement
treatment outcome
injections, subcutaneous
methotrexate
evaluation of the transparency committee
psoriasis
methotrexate
---
https://www.cosprc.ca/fr/enonce-de-position-conjoint-sur-la-technologie-au-plasma-pour-realiser-une-blepharoplastie-et-le-role-joue-par-les-medias-sociaux-dans-les-interventions-esthetiques/
2025
Canada
guideline
technology
achievement
spouses
role
blepharoplasty
social media
cheek
esthetics
plasma
blepharoplasty, nos
---
https://www.chu-lyon.fr/panaris
2025
France
popular works
paronychia
pulp abscess of finger, nos
---
https://www.has-sante.fr/jcms/p_3602228/fr/corevalve-evolut-r-avec-systeme-de-pose-enveo-pro
2025
France
health technology assessment
aorta
administration, cutaneous
arteries
implant, nos
artery, nos
bioprosthesis
application, nos
aorta, nos
---
https://www.has-sante.fr/jcms/p_3602240/fr/corevalve-evolut-pro-avec-systeme-de-pose-enveo-pro
2025
France
health technology assessment
bioprosthesis
artery, nos
administration, cutaneous
application, nos
aorta
implant, nos
aorta, nos
arteries
---
https://www.has-sante.fr/jcms/p_3556159/fr/dupixent-dupilumab-bronchopneumopathie-chronique-obstructive-bpco
2025
false
false
false
France
treatment outcome
insurance, health, reimbursement
adult
injections, subcutaneous
evaluation of the transparency committee
dupilumab
pulmonary disease, chronic obstructive
---
https://www.has-sante.fr/jcms/p_3576495/fr/spevigo-spesolimab-psoriasis-pustuleux-generalise-ppg
2025
false
false
false
France
insurance, health, reimbursement
treatment outcome
Generalized pustular psoriasis
Generalized pustular psoriasis flare
spesolimab
adult
adolescent
evaluation of the transparency committee
psoriasis
spesolimab
---
https://www.has-sante.fr/jcms/p_3539141/fr/simponi-golimumab-biotherapies-par-voie-sous-cutanee-dans-les-maladies-inflammatoires-chroniques
2024
false
false
false
France
drug prescriptions
evaluation of the transparency committee
chronic disease
biological therapy
golimumab
injections, subcutaneous
---
https://www.has-sante.fr/jcms/p_3539111/fr/humira-adalimumab-biotherapies-par-voie-sous-cutanee-dans-les-maladies-inflammatoires-chroniques
2024
false
false
false
France
drug prescriptions
evaluation of the transparency committee
chronic disease
biological therapy
adalimumab
Adalimumab
injections, subcutaneous
---
https://www.has-sante.fr/jcms/p_3539126/fr/dupixent-dupilumab-biotherapies-par-voie-sous-cutanee-dans-les-maladies-inflammatoires-chroniques
2024
false
false
false
France
drug prescriptions
evaluation of the transparency committee
chronic disease
biological therapy
dupilumab
injections, subcutaneous
---
https://www.has-sante.fr/jcms/p_3539096/fr/kyntheum-brodalumab-biotherapies-par-voie-sous-cutanee-dans-les-maladies-inflammatoires-chroniques
2024
false
false
false
France
drug prescriptions
evaluation of the transparency committee
biological therapy
chronic disease
brodalumab
injections, subcutaneous
---
https://www.has-sante.fr/jcms/p_3539105/fr/enbrel-etanercept-biotherapies-par-voie-sous-cutanee-dans-les-maladies-inflammatoires-chroniques
2024
false
false
false
France
drug prescriptions
-
evaluation of the transparency committee
injections, subcutaneous
biological therapy
Etanercept
chronic disease
---
https://www.has-sante.fr/jcms/p_3539102/fr/xolair-omalizumab-biotherapies-par-voie-sous-cutanee-dans-les-maladies-inflammatoires-chroniques
2024
false
false
false
France
drug prescriptions
evaluation of the transparency committee
Omalizumab
injections, subcutaneous
biological therapy
chronic disease
---
https://www.has-sante.fr/jcms/p_3539093/fr/stelara-ustekinumab-biotherapies-par-voie-sous-cutanee-dans-les-maladies-inflammatoires-chroniques
2024
false
false
false
France
drug prescriptions
evaluation of the transparency committee
injections, subcutaneous
Ustekinumab
chronic disease
biological therapy
---
https://www.has-sante.fr/jcms/p_3539090/fr/remsima-infliximab-biotherapies-par-voie-sous-cutanee-dans-les-maladies-inflammatoires-chroniques
2024
false
false
false
France
drug prescriptions
evaluation of the transparency committee
Infliximab
injections, subcutaneous
chronic disease
biological therapy
---
https://www.has-sante.fr/jcms/p_3539072/fr/cosentyx-secukinumab-biotherapies-par-voie-sous-cutanee-dans-les-maladies-inflammatoires-chroniques
2024
false
false
false
France
drug prescriptions
evaluation of the transparency committee
injections, subcutaneous
biological therapy
secukinumab
chronic disease
---
https://www.cochrane.org/fr/CD014932/SKIN_leducation-et-les-therapies-psychologiques-sont-elles-efficaces-pour-gerer-leczema
2024
United Kingdom
review of literature
french abstract
eczema, nos
eczema
therapy, nos
psychotherapy
psychology, educational
---
https://ansm.sante.fr/actualites/campagne-vaccinale-contre-les-infections-a-papillomavirus-humains-hpv-les-dernieres-donnees-confirment-de-nouveau-le-profil-de-securite-du-vaccin-gardasil-9
2024
false
false
false
France
French
papillomavirus infections
vaccination
papillomavirus vaccines
papillomavirus vaccines
drug information
pharmacovigilance
safety management
patient safety
papillomavirus (human types 6, 11, 16, 18, 31, 33, 45, 52,58)
---
https://www.cochrane.org/fr/CD014918/SKIN_les-traitements-topiques-la-phototherapie-et-les-therapies-complementaires-quelle-est-la-meilleure
2024
United Kingdom
review of literature
french abstract
phototherapy, nos
therapy, nos
phototherapy
acne, nos
protestantism
complication, nos
complementary therapies
acne
Acne
---
https://ansm.sante.fr/informations-de-securite/acetate-de-medroxyprogesterone-en-suspension-injectable-depo-prodasone-500-mg-risque-de-meningiome-et-mesures-de-reduction-du-risque
2024
false
false
false
France
French
risk management
meningioma
medroxyprogesterone acetate
injections, intramuscular
medroxyprogesterone
guidelines for drug use
---
https://www.cbip.be/fr/articles/4448?folia=4434
2024
false
false
false
Belgium
French
pharmacovigilance note
journal article
cyclosporine
risk
fibroadenoma
premenopause
---
https://ansm.sante.fr/tableau-marr/adamts13r
2024
false
false
false
France
French
risk management
ADAMTS13 Protein
guidelines for drug use
drug hypersensitivity
drug hypersensitivity
signs and symptoms
patient education handout
enzyme replacement therapy
adult
child
congenital thrombotic thrombocytopenic purpura
ADAMTS13 Protein
recombinant proteins
---
https://ansm.sante.fr/tableau-marr/etanercept-1
2024
false
false
false
France
French
risk management
Etanercept
patients guideline
drug information
Drug-Related side effects and adverse reactions
---
https://www.has-sante.fr/jcms/p_3465275/fr/dupixent-dupilumab-prurigo-nodulaire
2024
false
false
false
France
dupilumab
Prurigo nodularis (disorder)
adult
treatment outcome
insurance, health, reimbursement
evaluation of the transparency committee
dupilumab
prurigo
---
https://ansm.sante.fr/tableau-marr/pirfenidone
2024
false
false
false
France
French
guidelines for drug use
risk management
pirfenidone
pirfenidone
administration, oral
patient education handout
photosensitization
Drug-induced photosensitivity (disorder)
pirfenidone
Chemical and Drug Induced Liver Injury
continuity of patient care
liver function tests
Drug-Related side effects and adverse reactions
---
https://www.has-sante.fr/jcms/p_3482873/fr/cibinqo-abrocitinib-dermatite-atopique-da
2024
false
false
false
France
abrocitinib
treatment outcome
insurance, health, reimbursement
Janus Kinase Inhibitors
administration, oral
adult
evaluation of the transparency committee
dermatitis, atopic
abrocitinib
---
https://cps.ca/fr/documents/position/les-soins-peau-a-peau
2024
Canada
practice guideline
Premature Infant
Healthcare
infant care
Too Early
skin
nursing
infant
Skin Tear
Care
Preterm Birth
Reported Event Term
How True Feel Carefree Right Now
Healthcare Activity
infant, premature
immature
skin care
---
https://www.has-sante.fr/jcms/p_3487172/fr/botox-toxine-botulinique-type-a-blepharospasme-spasme-hemifacial-torticolis-spasmodique
2024
false
false
false
France
treatment outcome
insurance, health, reimbursement
botulinum toxin
neuromuscular agents
evaluation of the transparency committee
hemifacial spasm
botulinum toxins, type A
blepharospasm
torticollis
Spasmodic Torticollis
---
https://www.has-sante.fr/jcms/p_3478092/fr/taltz-ixekizumab-psoriasis-en-plaques-pediatrique
2024
false
false
false
France
evaluation of the transparency committee
Patch
Pediatric
bone plates
psoriasis
Taltz
Childhood-Onset Systemic Lupus Erythematosus
pediatrics
psoriasis vulgaris
Ixekizumab
ixekizumab
Psoriasis
Pediatricians
ixekizumab
pediatrician
Pediatric
---
https://www.has-sante.fr/jcms/p_3478083/fr/sivextro-phosphate-de-tedizolid-infections-de-la-peau
2024
false
false
false
France
adolescent
evaluation of the transparency committee
tedizolid phosphate
Infection
tedizolid phosphate
infectious disease, nos
Phosphate
Claudin-6
Tiludronate Disodium
phosphates
Tedizolid Phosphate
Skin
Slice
Murine Skin
Ivermectin
Sivextro
skin diseases, infectious
Thaw
Go Skating
---
https://ansm.sante.fr/tableau-marr/inhibiteur-de-la-c1-esterase-humaine
2024
false
false
false
France
French
risk management
guidelines for drug use
continuity of patient care
Human C1-Esterase Inhibitor
patients guideline
---
https://www.has-sante.fr/jcms/p_3488409/fr/libtayo-cemiplimab-cancer-bronchopulmonaire-non-a-petites-cellules-cbnpc
2024
false
false
false
France
treatment outcome
insurance, health, reimbursement
infusions, intravenous
Antineoplastic Agents, Immunological
cemiplimab
antibodies, monoclonal, humanized
antineoplastic combined chemotherapy protocols
adult
platinum compounds
PD-L1 Positive
evaluation of the transparency committee
carcinoma, non-small-cell lung
cemiplimab
---
https://www.has-sante.fr/jcms/p_3488284/fr/caspofungine-tillomed-caspofungine-antimycotique-a-usage-systemique
2024
false
false
false
France
drugs, generic
infusions, intravenous
caspofungin
evaluation of the transparency committee
Caspofungin
antifungal agents
---
https://www.has-sante.fr/jcms/p_3488174/fr/nplate-romiplostim-thrombopenie-immunologique-primaire-pti-refractaire-aux-autres-traitements
2024
false
false
false
France
Primary Immune Thrombocytopenia
evaluation of the transparency committee
nplate
principal
Romiplostim
Immunotherapy
romiplostim
Refractory
thrombocytopenia due to immune destruction, nos
Primary Refractory
romiplostim
idiopathic thrombocytopenic purpura, nos
Other Therapy
Immune
Immunology
thrombocytopenia
purpura, thrombocytopenic, idiopathic
immunology
---
https://www.has-sante.fr/jcms/p_3488635/fr/cabesol-clobetasol-psoriasis
2024
false
false
false
France
scalp dermatoses
administration, cutaneous
hair preparations
insurance, health, reimbursement
treatment outcome
glucocorticoids
clobetasol
Psoriasis of scalp (disorder)
evaluation of the transparency committee
clobetasol
psoriasis
---
https://www.has-sante.fr/jcms/p_3488641/fr/closalis-calcipotriol/betamethasone-psoriasis
2024
false
false
false
France
treatment outcome
insurance, health, reimbursement
drug combinations
betamethasone dipropionate, calcipotriol drug combination
calcipotriene
betamethasone-17,21-dipropionate
adult
calcipotriol, combinations
administration, cutaneous
ointments
Product containing precisely betamethasone (as betamethasone dipropionate) 500 microgram/1
gram and calcipotriol 50 microgram/1 gram conventional release cutaneous ointment
(clinical drug)
evaluation of the transparency committee
psoriasis
---
https://www.has-sante.fr/jcms/p_3490820/fr/opdualag-nivolumab/relatlimab-melanome
2024
false
false
false
France
treatment outcome
insurance, health, reimbursement
drug combinations
relatlimab
nivolumab and relatlimab
Nivolumab
Antineoplastic Agents, Immunological
infusions, intravenous
Unresectable Cutaneous Melanoma
adult
adolescent
PD-L1 Expression Less than 1 Percent
Advanced Cutaneous Melanoma
evaluation of the transparency committee
melanoma
---
https://www.cancer.fr/catalogue-des-publications/cancers-de-la-peau-s-informer-sur-les-risques-et-se-proteger-brochure
2024
false
false
false
France
patient education handout
Informed
Slice
Informative
Claudin-6
Go Skating
Murine Skin
Oprelvekin
Tiludronate Disodium
Ivermectin
No Information Available
Thaw
skin
Skin
risk
---
https://ansm.sante.fr/tableau-acces-derogatoire/itraconazole
2024
false
false
false
France
French
itraconazole
guidelines for drug use
administration, oral
tinea
child
microsporum
antifungal agents
itraconazole
continuity of patient care
---
https://www.has-sante.fr/jcms/p_3492674/fr/evolut-fx
2024
France
health technology assessment
TMSB4X wt Allele
Implantation Method of Administration
Murine Artery
Implanter Device
Aorta
Fetal Pathology Findings Domain
Implanted Medical Device
implant, nos
artery, nos
Thymosin Beta-4
Implant Dosage Form Category
F10 wt Allele
Metropolitan France
Sontuzumab
administration, cutaneous
Implant Dosage Form
GFUS wt Allele
Implantation
Alcohol Related Neurodevelopmental Disorder
aorta, nos
arteries
Implant Device Component
bioprosthesis
Artery
aorta
Administration via Implantation
Implant
CDISC SDTM Route of Administration Terminology
Implant Dosing Unit
---
https://www.canada.ca/fr/sante-publique/services/maladies-infectieuses/sante-sexuelle-infections-transmissibles-sexuellement/lignes-directrices-canadiennes/verrues-anogenitales.html
2024
Canada
guideline
LATS1 wt Allele
warts
papillomaviridae
warts
condylomata acuminata
Human Papillomavirus Viruses
KMT2A wt Allele
human papillomavirus, nos
condyloma acuminatum
Human Papillomavirus
---
https://ansm.sante.fr/tableau-marr/methotrexate-per-os
2024
false
false
false
France
French
guidelines for drug use
risk management
methotrexate
administration, oral
patient education handout
medication errors
---
https://ansm.sante.fr/tableau-marr/adalimumab
2024
false
false
false
France
French
Adalimumab
risk management
continuity of patient care
drug information
adult
child
patient education handout
---
https://www.has-sante.fr/jcms/p_3495394/fr/takhzyro-lanadelumab-angioedeme-hereditaire
2024
false
false
false
France
French
insurance, health, reimbursement
lanadelumab
evaluation of the transparency committee
child
angioedemas, hereditary
Hereditary angioedema attack
lanadelumab
treatment outcome
guidelines for drug use
Product containing precisely lanadelumab 150 milligram/1 milliliter conventional release
solution for injection (clinical drug)
---
https://www.fcvd.fr/wp-content/uploads/2024/02/Informations-avant-la-realisation-d-une-intervention-par-laser-pour-sinus-pilonidal-infecte-2.pdf
2024
France
patient education handout
Laser
Oprelvekin
Pilonidal Cyst
Infection
Informative
Intervention for Congenital Heart Disease
pilonidal sinus
achievement
Informed
laser
Intervention
No Information Available
pilonidal cyst with abscess
---
https://www.fcvd.fr/wp-content/uploads/2024/02/Informations-avant-traitement-chirurgical-d-un-sinus-pilonidal.pdf
2024
France
patient education handout
Disulfiram
On Treatment
Disposition Domain
Diethyl Sulfate
During Treatment
Unified Atomic Mass Unit
No Treatment for Diabetes
DHPS wt Allele
Disease Steps Clinical Classification
pilonidal sinus
Deci
Surgical Procedure
Informed
Day Imputed
information processing
Treat
Digestible Starch
Treatment Epoch
Therapy Object
Biomaterial Treatment
Treatment
Pilonidal Cyst
Informative
DNA
Day
No Information Available
pilonidal cyst, nos
GDC Treatment Frequency Terminology
Oprelvekin
Electronic Data Processing
Treatment Study
Surgical
---
https://soinsdenosenfants.cps.ca/handouts/pregnancy-and-babies/skin-to-skin-care-for-babies
2024
Canada
popular works
infant
skin
How True Feel Carefree Right Now
infant care
Healthcare
Care
Healthcare Activity
Skin Tear
nursing
skin care
---
https://www.has-sante.fr/jcms/p_3473151/fr/fiche-bum-dupixent-fasenra-nucala-tezspire-et-xolair-dans-le-traitement-de-l-asthme-severe
2024
false
false
false
France
dupilumab
benralizumab
mepolizumab
tezepelumab
other systemic drugs for obstructive airway diseases
adult
child
drug therapy, combination
Severe persistent asthma (disorder)
adolescent
Respiratory corticosteroid (substance)
adrenergic beta-2 receptor agonists
guidelines for drug use
Omalizumab
asthma
---
https://www.has-sante.fr/jcms/p_3423139/fr/spevigo-spesolimab-psoriasis-pustuleux-generalise-ppg
2024
false
false
false
France
Generalized pustular psoriasis
spesolimab
adult
treatment outcome
insurance, health, reimbursement
infusions, intravenous
evaluation of the transparency committee
psoriasis
spesolimab
---
https://ansm.sante.fr/tableau-marr/cemiplimab
2024
false
false
false
France
French
risk management
patients guideline
cemiplimab
Antineoplastic Agents, Immunological
infusions, intravenous
cemiplimab
drug monitoring
lymphohistiocytosis, hemophagocytic
drug information
lymphohistiocytosis, hemophagocytic
---
https://ansm.sante.fr/tableau-acces-derogatoire/dupixent
2024
false
false
false
France
French
summary of product characteristics
package leaflet
injections, subcutaneous
dupilumab
adult
Prurigo nodularis (disorder)
guidelines for drug use
prurigo
dupilumab
dermatitis, atopic
child
---
https://ansm.sante.fr/tableau-marr/leflunomide
2024
false
false
false
France
French
risk management
patients guideline
guidelines for drug use
Leflunomide
leflunomide
administration, oral
immunosuppressive agents
continuity of patient care
Drug-Related side effects and adverse reactions
---
https://ansm.sante.fr/tableau-acces-derogatoire/berinert-500-ui-mg-poudre-et-solvant-pour-solution-injectable-perfusion
2024
false
false
false
France
French
complement C1 inhibitor protein
guidelines for drug use
continuity of patient care
salvage therapy
graft rejection
Humoral rejection
heart transplantation
kidney transplantation
lung transplantation
infusions, intravenous
complement C1 inhibitor protein
technical report
---
https://ansm.sante.fr/tableau-marr/romiplostim
2024
false
false
false
France
French
injections, subcutaneous
romiplostim
risk management
romiplostim
guidelines for drug use
child
adult
patients guideline
clinical tool
home nursing
drug dosage calculations
self administration
receptors, fc
recombinant fusion proteins
thrombopoietin
---
https://www.has-sante.fr/jcms/p_3282449/fr/choix-et-duree-de-l-antibiotherapie-prise-en-charge-de-l-impetigo
2024
false
false
false
France
practice guideline
antibiotic therapy
patient care management
impetigo
duration
impetigo, nos
choice behavior
impetigo
Impetigo
---
https://ansm.sante.fr/tableau-marr/acitretine
2024
false
false
false
France
French
guidelines for drug use
patients guideline
risk management
teratogens
continuity of patient care
acitretin
acitretin
pregnancy
contraception
administration, oral
acitretin
mental disorders
drug monitoring
Chemical and Drug Induced Liver Injury
pancreatitis
psoriasis
Drug-Related side effects and adverse reactions
---
https://ansm.sante.fr/tableau-marr/alitretinoine
2024
false
false
false
France
French
guidelines for drug use
patients guideline
forms
administration, oral
teratogens
pregnancy
contraception
alitretinoin
mental disorders
dyslipidemias
continuity of patient care
pancreatitis
transaminases
Chemical and Drug Induced Liver Injury
drug monitoring
risk management
clinical chemistry tests
patient education handout
Drug-Related side effects and adverse reactions
Alitretinoin
Alitretinoin
---
https://ansm.sante.fr/tableau-marr/isotretinoine
2024
false
false
false
France
French
administration, oral
isotretinoin
risk management
acne vulgaris
isotretinoin
teratogens
pregnancy
contraception
mental disorders
dyslipidemias
Chemical and Drug Induced Liver Injury
patient education handout
forms
pancreatitis
guidelines for drug use
continuity of patient care
Drug-Related side effects and adverse reactions
---
https://www.ema.europa.eu/en/medicines/human/EPAR/adzynma
2024
false
false
false
Netherlands
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
orphan drug production
child
adult
congenital thrombotic thrombocytopenic purpura
enzyme replacement therapy
ADAMTS13 protein, human
recombinant proteins
ADAMTS13 Protein
ADAMTS13 Protein
risk management
pregnancy
breast feeding
drug approval
europe
injections, intravenous
von willebrand factor
product surveillance, postmarketing
aged
apadamtase alfa and cinaxadamtase alfa
---
https://minerva-ebp.be/FR/Analysis/884
2024
Belgium
critical appraisal or critical reading
prostatism, nos
activir
prostate
disease, nos
fenestration, nos
watchful waiting
risk
snacks
disease
Diseases Category
prostate, nos
prostate symptom/complaint
---
https://www.has-sante.fr/jcms/p_3562973/fr/bimzelx-bimekizumab-hidradenite-suppuree-maladie-de-verneuil
2024
false
false
false
France
treatment outcome
insurance, health, reimbursement
bimekizumab
Interleukin-17A
Interleukin-17F
Interleukin Inhibitors
adult
evaluation of the transparency committee
hidradenitis suppurativa
bimekizumab
---
https://www.has-sante.fr/jcms/p_3563547/fr/depistage-de-la-tuberculose-latente-via-un-test-de-detection-de-la-production-d-interferon-gamma-igra-avant-initiation-d-un-traitement-par-un-medicament-de-la-classe-des-anti-jak-dont-sotyktu-deucravacitinib
2024
France
health technology assessment
drug therapy
tuberculosis, nos
production
filing
deucravacitinib
latent tuberculosis
interferon-gamma release tests
screening
economics
gamma interferon
interferon-gamma
deucravacitinib
Janus Kinase Inhibitors
detective
drug, nos
mass screening
tuberculosis
dermatomyositis
---
https://ansm.sante.fr/tableau-marr/nivolumab-relatlimab
2024
false
false
false
France
French
patients guideline
Drug-Related side effects and adverse reactions
Drug-Related side effects and adverse reactions
signs and symptoms
drug information
drug combinations
Nivolumab
relatlimab
---
https://www.santepubliquefrance.fr/determinants-de-sante/pollution-et-sante/air/documents/enquetes-etudes/agir-sur-les-espaces-verts-les-mobilites-actives-la-chaleur-la-pollution-de-l-air-et-le-bruit-quels-benefices-pour-la-sante-synthese-des-res
2024
France
technical report
air pollution
activir
heat, nos
hot temperature
fracture fixation
mobility, nos
resulting in
health
air pollution
activator appliances
noise polution
heat
noise
---
https://www.santepubliquefrance.fr/regions/normandie/documents/enquetes-etudes/2024/agir-sur-les-espaces-verts-les-mobilites-actives-la-chaleur-la-pollution-de-l-air-et-le-bruit-quels-benefices-pour-la-sante-synthese-des-res
2024
France
technical report
activir
health
fracture fixation
air pollution
resulting in
noise
heat, nos
noise polution
activator appliances
mobility, nos
heat
air pollution
hot temperature
---
https://www.anses.fr/fr/content/produits-de-protection-solaire-mieux-informer-les-consommateurs-pour-une-meilleure-protection
2024
France
popular works
information protection
economics
computer security
sunscreening agents
---
https://www.has-sante.fr/jcms/p_3552132/fr/activa-rc
2024
France
health technology assessment
activir
double
stimulator, nos
deep brain stimulation
activator appliances
brain, nos
---
https://www.has-sante.fr/jcms/p_3552138/fr/activa-sc
2024
France
health technology assessment
stimulator, nos
deep brain stimulation
activir
brain, nos
activator appliances
---
https://www.orpha.net/data/patho/Emg/Int/fr/Dermatomyosite_FR_fr_EMG_ORPHA221.pdf
2024
France
guideline
dermatomyositis
dermatomyositis
best practices
childhood type dermatomyositis
snacks
dermatomyositis, adult type
emergencies
---
https://www.louvainmedical.be/fr/article/comment-aborder-la-premiere-ligne-therapeutique-dans-le-carcinome-renal-cellules-claires
2024
Belgium
journal article
combined
clear cell renal cell carcinoma
clear cell adenocarcinoma, nos
kidney, nos
metastatic to
activir
immunotherapy
immunotherapy, nos
carcinoma, renal cell
base, nos
therapeutics
watchful waiting
---
https://www.chu-lyon.fr/ulcere-cutane
2024
France
patient education handout
skin ulcer
ulcer of skin, nos
---
https://www.cochrane.org/fr/CD014040/CENTRALED_activation-des-ovocytes-chez-les-femmes-apres-injection-intracytoplasmique-de-spermatozoides-icsi
2024
United Kingdom
review of literature
french abstract
oocytes
sperm injections, intracytoplasmic
spermatozoa
activir
women
injection, nos
women, working
---
https://www.chu-lyon.fr/eczema-dermatite-de-contact
2024
France
popular works
contact dermatitis, nos
eczema, nos
dermatitis, contact
dermatitis
---
https://www.chu-lyon.fr/psoriasis-cutane
2024
France
popular works
psoriasis, nos
psoriasis
skin, nos
---
https://www.has-sante.fr/jcms/p_3498562/fr/adtralza-tralokinumab-dermatite-atopique-chez-l-adulte-et-l-adolescent-a-partir-de-12-ans
2024
false
false
false
France
tralokinumab
injections, subcutaneous
adolescent
adult
dermatitis, atopic
Adult atopic dermatitis (disorder)
evaluation of the transparency committee
tralokinumab
---
https://www.has-sante.fr/jcms/p_3498741/fr/takhzyro-lanadelumab-angiooedeme-hereditaire
2024
false
false
false
France
antibodies, monoclonal, humanized
treatment outcome
insurance, health, reimbursement
angioedemas, hereditary
child
lanadelumab
Product containing precisely lanadelumab 150 milligram/1 milliliter conventional release
solution for injection (clinical drug)
Hereditary angioedema attack
evaluation of the transparency committee
lanadelumab
---
https://www.has-sante.fr/jcms/p_3500387/fr/dupixent-dupilumab-dermatite-atopique
2024
false
false
false
France
treatment outcome
insurance, health, reimbursement
dupilumab
injections, subcutaneous
adult
Adult atopic dermatitis (disorder)
evaluation of the transparency committee
dermatitis, atopic
dupilumab
---
https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/protocole-medical-national-initier-un-test-immunochimique-de-recherche-de-sang-occulte-dans-les-selles-ou-une-coloscopie-a-des-fins-de-depistage-ou-de-diagnostic-du-cancer-colorectal.html
2024
Canada
public health guidelines
Test Name
immunochemistry
colonoscopy
On Study
screening for cancer
dermatomyositis
Colorectal Cancer
Cancer Diagnosis
biomedical research
Laboratory Procedure
Screening Colonoscopy
Test Dosing Unit
Screening for Colorectal Cancer
cancer screening
malignant neoplasm colon/rectum
early detection of cancer
Initiation
diagnosis
no diagnosis
Fecal Occult Blood Test
Blood Products Laboratory Testing
feces
screening for occult blood in feces
Clinical Study Protocol
medical research
colorectal neoplasms
occult blood
---
https://www.has-sante.fr/jcms/p_3500011/fr/bimzelx-bimekizumab-psoriasis-en-plaques
2024
false
false
false
France
treatment outcome
insurance, health, reimbursement
adult
injections, subcutaneous
bimekizumab
evaluation of the transparency committee
psoriasis
bimekizumab
---
https://www.has-sante.fr/jcms/p_3501627/fr/skyrizi-risankizumab-maladie-de-crohn
2024
false
false
false
France
treatment outcome
insurance, health, reimbursement
adult
infusions, intravenous
injections, subcutaneous
Interleukin Inhibitors
risankizumab
evaluation of the transparency committee
crohn disease
risankizumab
---
https://www.has-sante.fr/jcms/p_3501976/fr/cosentyx-secukinumab-rhumatisme-psoriasique
2024
false
false
false
France
treatment outcome
insurance, health, reimbursement
secukinumab
injections, subcutaneous
Interleukin Inhibitors
adult
Interleukin-17
evaluation of the transparency committee
arthritis, psoriatic
secukinumab
---
https://www.cbip.be/fr/articles/4279?folia=4275
2024
false
false
false
Belgium
French
Dutch
journal article
eczema
child
emollients
---
https://ansm.sante.fr/actualites/decision-du-21-03-2024-cadre-de-prescription-compassionnelle-de-tacrolimus-0-1-pommade
2024
false
false
false
France
French
drug information
tacrolimus
administration, cutaneous
ointments
legislation, pharmacy
adult
child
adolescent
vitiligo
tacrolimus
---
https://ansm.sante.fr/tableau-acces-derogatoire/tacrolimus#
2024
false
false
false
France
French
tacrolimus
drug information
administration, cutaneous
vitiligo
---
https://www.has-sante.fr/jcms/p_3505844/fr/litfulo-ritlecitinib-pelade
2024
false
false
false
France
treatment outcome
insurance, health, reimbursement
adult
adolescent
administration, oral
ritlecitinib
Janus Kinase Inhibitors
immunosuppressive agents
evaluation of the transparency committee
Ritlecitinib
alopecia areata
---
https://www.reiso.org/articles/themes/vieillesse/12246-participation-active-pour-le-vieillissement-en-sante
2024
Switzerland
journal article
Password Aging
activator appliances
health
Participation
aging
Aging
aging
activir
Activation
---
https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/depistage-cancer-uterus-recommandations.html
2024
Canada
public health guidelines
early detection of cancer
Cervical Carcinoma
implantation in uterus, nos
Implantation Method of Administration
Detection
Test Dosing Unit
papillomaviridae
Human Papillomavirus Viruses
Cervical Cancer pT1a1 TNM Finding v8
Primary
cancer screening
uterine cervical neoplasms
prostheses and implants
Blood Products Laboratory Testing
Prior Primary
Test Name
dermatomyositis
malignant neoplasm cervix
screening for cancer
Administration via Implantation
Human Papillomavirus
Cervical Cancer Screening
Biological Detection Test
quebec
Altretamine/Etoposide/Procarbazine
human papillomavirus, nos
cancer of the uterine cervix
principal
Primary Cause of Death
detective
health planning guidelines
Implantation
---
https://ansm.sante.fr/actualites/campagne-vaccinale-contre-les-infections-a-papillomavirus-humains-hpv-les-donnees-recueillies-apres-la-premiere-dose-confirment-le-profil-de-securite-du-vaccin-gardasil-9
2024
false
false
false
France
French
papillomavirus vaccines
papillomavirus infections
vaccine safety
Human Papillomavirus Recombinant Vaccine nonavalent
mass vaccination
Vaccination Campaign
technical report
adolescent
vaccination
---
https://ansm.sante.fr/actualites/decision-du-25-04-2024-cadre-de-prescription-compassionnelle-de-botox-50-100-et-200-unites-allergan-poudre-pour-solution-injectable
2024
false
false
false
France
French
botulinum toxins, type A
drug information
neuralgia
Chronic peripheral neuropathic pain (finding)
---
https://ansm.sante.fr/tableau-acces-derogatoire/botox
2024
false
false
false
France
French
guidelines for drug use
botulinum toxins, type A
neuralgia
chronic disease
adult
Chronic peripheral neuropathic pain (finding)
---
https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/dosage-plasmatique-du-linezolide.html
2024
Canada
health technology assessment
Bioassay
Linezolid
Linezolid
Assessment
Cumulative Dose
---
https://www.has-sante.fr/jcms/p_3518649/fr/ilaris-canakinumab-crise-d-arthrite-goutteuse
2024
false
false
false
France
treatment outcome
insurance, health, reimbursement
Acute gout (disorder)
canakinumab
injections, subcutaneous
evaluation of the transparency committee
canakinumab
arthritis, gouty
---
https://pap-pediatrie.fr/allergo-pneumo/urticaire-chronique-de-lenfant
2024
France
scientific and technical information
algorithms
chronic urticaria
child, nos
Child Individual
child
Chronic Urticaria
Chronic Graft Versus Host Disease
Urticaria
urticaria
Child Relation
---
https://www.rheuma-net.ch/fr/doc/cyclophosphamid-1/viewdocument/348
2024
Switzerland
guideline
cyclophosphamide
cyclophosphamide
Background Treatment
Cyclophosphamide
---
https://www.ema.europa.eu/en/medicines/human/EPAR/pyzchiva
2024
false
false
false
Netherlands
French
English
Ustekinumab
Ustekinumab
drug approval
europe
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
biosimilar pharmaceuticals
ustekinumab
psoriasis
arthritis, psoriatic
drug interactions
pregnancy
breast feeding
crohn disease
colitis, ulcerative
Product containing only ustekinumab in parenteral dose form (medicinal product form)
infusions, intravenous
Interleukin Inhibitors
Interleukin Inhibitors
Interleukin-12
Interleukin-23
injections, subcutaneous
---
https://www.ema.europa.eu/en/medicines/human/EPAR/uzpruvo
2024
false
false
false
Netherlands
French
English
drug approval
europe
Ustekinumab
Ustekinumab
syndication feed
summary of product characteristics
package leaflet
drug evaluation
biosimilar pharmaceuticals
---
https://www.has-sante.fr/jcms/p_3524692/fr/daktarin-miconazole-antifongique
2024
false
false
false
France
insurance, health, reimbursement
-
miconazole
evaluation of the transparency committee
antifungal agents
miconazole
---
https://www.inrs.fr/media.html?refINRS=TA%20106
2024
France
journal article
Cup Dosing Unit
occupational eczema
dermatitis, occupational
Cup
Contact Dermatitis
contact dermatitis, nos
Cup Device
Body Fluid or Substance
---
https://www.inrs.fr/media.html?refINRS=TD%20313
2024
France
journal article
Occupation
trial labor
activation test
trial of labor
living conditions
living condition, nos
Activate
activir
social conditions
Activation
Work
activator appliances
Expander Device
Computer Job
Working Conditions
Active Indicator
Worksite
Activator
---
https://ansm.sante.fr/actualites/a-compter-du-10-07-2024-la-cyproheptadine-periactine-4mg-sera-dispensee-uniquement-sur-ordonnance
2024
false
false
false
France
French
drug information
cyproheptadine
cyproheptadine
prescription drugs
Off-Label use
---
https://www.has-sante.fr/jcms/p_3527216/fr/afinitor-everolimus-tumeurs-neuroendocrines-d-origine-pancreatique
2024
false
false
false
France
pancreatic neoplasms
treatment outcome
insurance, health, reimbursement
disease progression
adult
Metastatic Pancreatic Neuroendocrine Tumor
Unresectable Pancreatic Neuroendocrine Tumor
administration, oral
antineoplastic agents
everolimus
evaluation of the transparency committee
neuroendocrine tumors
Everolimus
---
https://www.canal-u.tv/chaines/ub/jeu-de-maux-episode-4-l-etymologie-la-terminologie-des-mots-de-la-dermatologie-partie-1
2024
France
audiovisual aids
episode of
Intensity and Distress 1
Thought Score 4
etymology
Intensity and Distress 4
Symptoms Extent Score 1
Agreement Score 4
Clinical Status Ordinal Scale Outcome 4
CDISC SDTM Model Version 1.6
1+ Score
Clinical Status Ordinal Scale Outcome 1
Symptoms Extent Score 4
Afghanistan
Fear Score 4
Upset Score 1
ECOG Performance Status 1
CDISC SDTM Model Version 1.5
Gleason Grade Group 1
Episode
Thought Score 1
Mild Adverse Event
Integumentary System Finding
Gleason Grade Group 4
Nomenclature
1+ Score, WHO
Illness Intrusiveness Rating 4
One Full Term Pregnancy
Neck Pain Score 1
Dermatologist
Severity of Symptom Score 4
dermatology
Phase IV Trial
Upset Score 4
Terminology
One Hundred Percent
One
Four
Severity of Symptom Score 1
Illness Intrusiveness Rating 1
terminology as topic
terminology
Fear Score 1
ECOG Performance Status 4
Phase I Trial
Tumor Regression Score 1
Never Smoker
Current Reformed Smoker Within Past 15 Years
Agreement Score 1
---
https://www.canal-u.tv/chaines/ub/jeu-de-maux-episode-5-l-etymologie-la-terminologie-des-mots-de-la-dermatologie-partie-2
2024
France
audiovisual aids
ECOG Performance Status 5
Phase V Trial
Illness Intrusiveness Rating 5
terminology as topic
Clinical Status Ordinal Scale Outcome 5
Intensity and Distress 5
Fear Score 5
Death Related to Adverse Event
etymology
Loss of Chromosome 5
Nomenclature
Episode
terminology
Dermatologist
Upset Score 5
episode of
Neck Pain Score 5
dermatology
Severity of Symptom Score 5
Thought Score 5
Current Reformed Smoker, Years Unknown
Terminology
Agreement Score 5
Gleason Grade Group 5
Integumentary System Finding
---
https://www.has-sante.fr/jcms/p_3530407/fr/cyclophosphamide-accord-cyclophosphamide-cancer-et-maladies-auto-immunes
2024
false
false
false
France
treatment outcome
insurance, health, reimbursement
Product containing only cyclophosphamide in parenteral dose form (medicinal product
form)
precursor cell lymphoblastic Leukemia-Lymphoma
cyclophosphamide
transplantation conditioning
multiple myeloma
hodgkin disease
lymphoma, Non-Hodgkin
ovarian neoplasms
breast neoplasms
neoplasm metastasis
sarcoma, ewing
small cell lung carcinoma
bronchial neoplasms
neuroblastoma
lupus nephritis
Granulomatosis with Polyangiitis
myeloablative agonists
antineoplastic agents, alkylating
immunosuppressive agents
evaluation of the transparency committee
cyclophosphamide
autoimmune diseases
---
https://www.pedia-univ.fr/deuxieme-cycle/referentiel/hematologie-cancerologie/purpura
2024
France
educational course
purpura
Purpura
Purpura, CTCAE
purpura, nos
---
https://www.cancer.fr/catalogue-des-publications/depliant-guide-pratique_depistage-du-cancer-colorectal-2024
2024
false
false
false
France
patient education handout
Leaflet
Handbook
Blood Products Laboratory Testing
Leaflet Device
cancer screening
Autonomic Nervous System
dermatomyositis
ego
screening for cancer
Test Name
Guide Device
Broadside
Screening for Colorectal Cancer
Laboratory Procedure
malignant neoplasm colon/rectum
self
Test Dosing Unit
Splayed
early detection of cancer
colorectal neoplasms
Colorectal Cancer
---
https://www.has-sante.fr/jcms/p_3534482/fr/xydalba-dalbavancine-antibiotique
2024
false
false
false
France
treatment outcome
insurance, health, reimbursement
Dalbavancin hydrochloride (substance)
dalbavancin
infusions, intravenous
infant
child
adolescent
acute disease
skin diseases, bacterial
soft tissue infections
evaluation of the transparency committee
dalbavancin
anti-bacterial agents
---
https://montestprevention.e-cancer.fr/
2024
France
popular works
Prevention Study
Laboratory Procedure
Prevention
Preventive Intervention
Blood Products Laboratory Testing
dermatomyositis
Test Name
Test Dosing Unit
---
https://ansm.sante.fr/informations-de-securite/crayon-au-nitrate-dargent-restriction-des-indications-et-rappel-des-risques
2024
false
false
false
France
French
guidelines for drug use
pharmacovigilance note
silver nitrate
silver nitrate
risk
---
https://ansm.sante.fr/tableau-marr/voriconazole
2024
false
false
false
France
French
risk management
Voriconazole
antifungal agents
drug information
patients guideline
dermatitis, phototoxic
dermatitis, phototoxic
risk
skin neoplasms
skin neoplasms
Skin Squamous Cell Carcinoma
Skin Squamous Cell Carcinoma
voriconazole
---
https://www.has-sante.fr/jcms/p_3538222/fr/cibinqo-abrocitinib-dermatite-atopique-des-12-ans
2024
false
false
false
France
adolescent
treatment outcome
insurance, health, reimbursement
Janus Kinase Inhibitors
administration, oral
abrocitinib
evaluation of the transparency committee
dermatitis, atopic
abrocitinib
---
https://www.srlf.org/article/tazocilline-cefepime-reanimation-qui-fait-mieux
2024
France
critical appraisal or critical reading
Cefepime
Device Properties Domain
Reasoning
What Month is it
Dong Chinese
Resuscitation
Cefepime
Foundation for the Accreditation of Cellular Therapy
Doctor of Osteopathic Medicine
Better than Others
cefepime
resuscitation
Improved
Dominican Republic
---
https://www.has-sante.fr/jcms/p_3539087/fr/adtralza-tralokinumab-maladies-inflammatoires-chroniques
2024
false
false
false
France
biological therapy
drug prescriptions
tralokinumab
evaluation of the transparency committee
administration, cutaneous
tralokinumab
---
https://www.has-sante.fr/jcms/p_3539120/fr/bimzelx-bimekizumab-biotherapies-par-voie-sous-cutanee-dans-les-maladies-inflammatoires-chroniques
2024
false
false
false
France
drug prescriptions
evaluation of the transparency committee
bimekizumab
chronic disease
biological therapy
injections, subcutaneous
---
https://www.cfp.ca/content/70/9/e134
2024
Canada
journal article
corticoids
dermatitis, atopic
adrenal cortex hormones
dermatitis
topical corticosteroid, nos
atopic dermatitis, nos
---
https://www.has-sante.fr/jcms/p_3539108/fr/skyrizi-risankizumab-biotherapies-par-voie-sous-cutanee-dans-les-maladies-inflammatoires-chroniques
2024
false
false
false
France
drug prescriptions
evaluation of the transparency committee
risankizumab
chronic disease
injections, subcutaneous
biological therapy
---
https://www.has-sante.fr/jcms/p_3539132/fr/ilumetri-tildrakizumab-biotherapies-par-voie-sous-cutanee-dans-les-maladies-inflammatoires-chroniques
2024
false
false
false
France
drug prescriptions
evaluation of the transparency committee
biological therapy
injections, subcutaneous
chronic disease
tildrakizumab
---
https://www.has-sante.fr/jcms/p_3539078/fr/tenkasi-oritavancine-antibacteriens-glycopeptides
2024
false
false
false
France
vancomycin
treatment outcome
insurance, health, reimbursement
oritavancin
Product containing only oritavancin (medicinal product)
staphylococcal skin infections
staphylococcal infections
soft tissue infections
adult
Skin infection caused by Methicillin resistant Staphylococcus aureus (disorder)
infusions, intravenous
evaluation of the transparency committee
anti-bacterial agents
Lipoglycopeptides
oritavancin
---
https://www.has-sante.fr/jcms/p_3539069/fr/ilaris-canakinumab-biotherapies-par-voie-sous-cutanee-dans-les-maladies-inflammatoires-chroniques
2024
false
false
false
France
drug prescriptions
evaluation of the transparency committee
canakinumab
injections, subcutaneous
chronic disease
biological therapy
---
https://www.has-sante.fr/jcms/p_3539114/fr/cimzia-certolizumab-pegol-biotherapies-par-voie-sous-cutanee-dans-les-maladies-inflammatoires-chroniques
2024
false
false
false
France
drug prescriptions
evaluation of the transparency committee
biological therapy
injections, subcutaneous
Certolizumab Pegol
chronic disease
---
https://www.has-sante.fr/jcms/p_3539084/fr/tremfya-guselkumab-biotherapies-par-voie-sous-cutanee-dans-les-maladies-inflammatoires-chroniques
2024
false
false
false
France
drug prescriptions
evaluation of the transparency committee
injections, subcutaneous
guselkumab
biological therapy
chronic disease
---
https://www.has-sante.fr/jcms/p_3540394/fr/chloraprep-gluconate-de-chlorhexidine-/-alcool-isopropylique-antisepsie
2024
false
false
false
France
drug combinations
insurance, health, reimbursement
administration, cutaneous
Impregnated cutaneous swab
Preoperative disinfection of skin (procedure)
evaluation of the transparency committee
antisepsis
2-Propanol
chlorhexidine gluconate
chlorhexidine
---
https://www.has-sante.fr/jcms/p_3433401/fr/dupixent-dupilumab-dermatite-atopique-severe-de-l-enfant-age-de-6-mois-a-5-ans
2023
false
false
false
France
infant
insurance, health, reimbursement
treatment outcome
dupilumab
Childhood atopic dermatitis (disorder)
injections, subcutaneous
receptors, interleukin
evaluation of the transparency committee
child
dermatitis, atopic
dupilumab
---
https://www.inesss.qc.ca/publications/repertoire-des-publications/publication/pertinence-dajouter-les-variantes-hbs-e-hbe-e-et-hbe-b-thal-aux-cibles-primaires-du-test-de-depistage-neonatal-des-hemoglobinopathies.html
2023
Canada
public health guidelines
hemoglobinopathy, nos
hemoglobinopathies
principal
neonatal screening, nos
Hemoglobinopathy
neonatal screening
dermatomyositis
---
https://www.has-sante.fr/jcms/p_3434154/fr/telfast-chlorhydrate-de-fexofenadine-rhinite-allergique-saisonniere-et-prurit-au-cours-de-l-urticaire-chronique
2023
false
false
false
France
-
-
insurance, health, reimbursement
evaluation of the transparency committee
fexofenadine hydrochloride
fexofenadine
---
http://nuxeo.edel.univ-poitiers.fr/nuxeo/site/esupversions/dda32ff9-7ea7-43de-9b76-dfa1836a68e4
2023
France
Physicians
activir
aged
case management
disease
has patient
patient care
role
activator appliances
principal
physician's role
medicine
physicians
hematology
primary health care
physicians, primary care
antineoplastic agents
Hematology
---
https://www.has-sante.fr/jcms/p_3434489/fr/ilumetri-tildrakizumab-psoriasis-en-plaques
2023
false
false
false
France
evaluation of the transparency committee
tildrakizumab
psoriasis
---
https://ansm.sante.fr/informations-de-securite/attention-au-risque-derreur-medicamenteuse-de-surdose-accidentelle-avec-la-nouvelle-pipette-de-theralene
2023
false
false
false
France
French
medication errors
pharmacovigilance note
trimeprazine
pharmaceutical solutions
administration, oral
---
https://pap-pediatrie.fr/dermatologie/eruption-cutanee-febrile-de-lenfant
2023
France
algorithms
exanthema
child
Child
cutaneous eruption, nos
Child
Child
increased body temperature
child, nos
Child
---
https://www.cochrane.org/fr/CD014816/MUSKEL_quels-sont-les-benefices-et-les-risques-de-lexercice-physique-pour-les-personnes-atteintes-de-lupus
2023
United Kingdom
review of literature
french abstract
risks and benefits
risk assessment
physical exercise, nos
exercise
Dissemination
systemic lupus erythematosus
Physics
disease
persons
lupus erythematosus, systemic
Systemic lupus erythematosus
---
https://ansm.sante.fr/dossiers-thematiques/vaccins-contre-les-infections-a-papillomavirus-humains-hpv
2023
false
false
false
France
French
drug information
papillomavirus vaccines
papillomavirus infections
vaccine potency
papillomavirus vaccines
france
papillomavirus vaccines
---
https://www.ema.europa.eu/en/medicines/human/EPAR/opzelura
2023
false
false
false
Netherlands
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
drug approval
europe
ruxolitinib
ruxolitinib
ruxolitinib
vitiligo
adult
adolescent
administration, cutaneous
ointments
Janus Kinase Inhibitors
Janus Kinase Inhibitors
JAK1 Inhibitor
JAK2 Inhibitor
janus kinase 1
janus kinase 2
ruxolitinib phosphate
ruxolitinib phosphate
aged
drug interactions
pregnancy
breast feeding
drug evaluation, preclinical
---
https://www.has-sante.fr/jcms/p_3446078/fr/diprosone-betamethasone-/-diprosalic-betamethasone-/-acide-salicylique-corticoides
2023
false
false
false
France
treatment outcome
insurance, health, reimbursement
drug combinations
administration, cutaneous
evaluation of the transparency committee
salicylic acid
corticoids
betamethasone
glucocorticoids
---
https://ansm.sante.fr/dossiers-thematiques/le-point-sur-vos-traitements
2023
false
false
false
France
French
guidelines for drug use
patients guideline
hot temperature
pharmaceutical preparations
heat
extreme heat
travel
drug storage
Blood glucose meter (physical object)
Drug-induced photosensitivity (disorder)
---
http://www.lecrat.eu/?s=Canakinumab+-+Grossesse+et+allaitement
2023
false
false
false
France
French
drug information
pregnancy
breast feeding
canakinumab
---
https://ansm.sante.fr/tableau-marr/abrocitinib
2023
false
false
false
France
French
risk management
abrocitinib
abrocitinib
administration, oral
Drug-Related side effects and adverse reactions
guidelines for drug use
patient education handout
---
https://www.has-sante.fr/jcms/p_3448567/fr/theralene-alimemazine-insomnie
2023
false
false
false
France
insurance, health, reimbursement
administration, oral
alimemazine
histamine h1 antagonists
evaluation of the transparency committee
trimeprazine
sleep initiation and maintenance disorders
---
https://www.who.int/fr/publications-detail/9789240068988
2023
Switzerland
technical report
evaluation studies as topic
cell adhesion molecules
fever
detective
organization and administration
world health organization
Virus
immunoglobulin M
albumin/globulin ratio
Viruses
yellow fever virus
evaluation report
complementary therapies
Yellow fever
yellow fever virus
dermatomyositis
Yellow fever
---
https://www.louvainmedical.be/fr/article/comorbidites-de-la-dermatite-atopique
2023
Belgium
journal article
Atopic dermatitis
comorbidity
Polypathology
atopic dermatitis, nos
dermatitis
dermatitis, atopic
---
https://ansm.sante.fr/tableau-marr/etanercept
2023
false
false
false
France
French
patients guideline
drug information
biosimilar pharmaceuticals
risk management
---
https://www.has-sante.fr/jcms/p_3447378/fr/ultrasound-guided-transcutaneous-venous-occlusion-of-the-small-saphenous-vein-inahta-brief
2023
false
false
false
France
health technology assessment
obstruction, nos
lesser saphenous vein
ultrasonic guidance procedure, nos
vein, nos
administration, intravenous
administration, cutaneous
ultrasonography
saphenous vein
---
https://www.has-sante.fr/jcms/p_3455976/fr/venusp-valve
2023
France
health technology assessment
administration, intravenous
pulmonaria
bioprosthesis
vein, nos
administration, cutaneous
lung, nos
implant, nos
---
https://www.has-sante.fr/jcms/p_3456145/fr/physiogine-estriol-affections-vulvo-vaginales
2023
false
false
false
France
administration, intravaginal
vaginal suppositories
insurance, health, reimbursement
estriol
estrogen replacement therapy
evaluation of the transparency committee
vaginal diseases
estriol
---
https://www.who.int/fr/publications-detail/9789240068957
https://iris.who.int/handle/10665/371100
2023
false
false
false
Switzerland
technical report
world health organization
immunoglobulin M
reference standards
yellow fever virus
fever
Viruses
evaluation studies as topic
organization and administration
albumin/globulin ratio
telephone switchboard operator
evaluation report
Yellow fever
yellow fever virus
detective
Virus
Yellow fever
dermatomyositis
---
https://www.has-sante.fr/jcms/p_3460130/fr/adtralza-tralokinumab-dermatite-atopique-chez-l-adolescent-a-partir-de-12-ans
2023
false
false
false
France
treatment outcome
insurance, health, reimbursement
tralokinumab
injections, subcutaneous
evaluation of the transparency committee
tralokinumab
dermatitis, atopic
adolescent
---
https://www.hcsp.fr/explore.cgi/avisrapportsdomaine?clefr=1328
2023
France
scientific and technical information
virus activation
human virus, nos
postal service
activir
human body
west nile virus
Virus
Viruses
mail
---
https://dumas.ccsd.cnrs.fr/dumas-04146539
2023
France
dissertations, academic
acne
patient care management
acne, nos
Acne
Acne
Charge
---
https://pepite-depot.univ-lille.fr/RESTREINT/Th_Medecine/2023/2023ULILM090.pdf
2023
France
dissertations, academic
occupational eczema
No Cases Transmission Pattern
Product Description/Appearance Assessment
Allergic Contact Dermatitis
snacks
Coronavirus Anxiety Scale
BCAR1 wt Allele
review literature as topic
Catenin Delta-1
contact dermatitis, nos
Packaging Case
Breast Cancer Anti-Estrogen Resistance Protein 1
CTNND1 wt Allele
Case Dosing Unit
Description
Case
Reviewing
True Case Status
dermatitis, allergic contact
atopic dermatitis, nos
dermatitis, occupational
---
https://minerva-ebp.be/FR/Analysis/832
2023
Belgium
critical appraisal or critical reading
Nonclinical Randomization
choice behavior
Localized Malignant Neoplasm
case study
malignant neoplasm prostate
Locally Advanced Malignant Neoplasm
prostatic neoplasms
Cancer Risk
prostate cancer
survival
general surgery
neoplasm, malignant
International Prognostic Index Low Risk Group
American College of Cardiology/American Heart Association Lesion Complexity Score
A
resulting in
Long-Term
Prostate Cancer Outcomes Study
radiotherapy
Drug Accumulation 1.2 to 1.99
asthenia
activir
Similarity
Patient Observation
operative procedure, nos
snacks
watchful waiting
Case Series
risk
sampling studies
Case Study
IPSS-R Risk Category Low
radiation therapy, nos
Low Risk
outcome studies
Therapeutic Skin Surgery
X-ray Therapy
prostate, nos
Disease Risk Index Low Risk
Choose
Cancer Survivorship Research
therapeutics
---
https://www.has-sante.fr/jcms/p_3461359/fr/libtayo-cemiplimab-carcinome-epidermoide-cutane-metastatique-ou-localement-avance-cecm-ou-cecla
2023
false
false
false
France
skin neoplasms
treatment outcome
insurance, health, reimbursement
Metastatic Skin Squamous Cell Carcinoma
Locally Advanced Skin Squamous Cell Carcinoma
infusions, intravenous
Antineoplastic Agents, Immunological
cemiplimab
antibodies, monoclonal, humanized
evaluation of the transparency committee
cemiplimab
carcinoma, squamous cell
---
https://www.ema.europa.eu/en/medicines/human/EPAR/litfulo
2023
false
false
false
Netherlands
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
Ritlecitinib
Ritlecitinib
drug approval
europe
Janus Kinase Inhibitors
Janus Kinase Inhibitors
ritlecitinib
adult
adolescent
alopecia areata
administration, oral
continuity of patient care
immunosuppressive agents
immunosuppressive agents
product surveillance, postmarketing
drug interactions
pregnancy
breast feeding
Female of Childbearing Potential
drug evaluation, preclinical
---
https://ansm.sante.fr/informations-de-securite/simponi-golimumab-50-mg-et-100-mg-modifications-importantes-des-instructions-dutilisation-du-stylo-prerempli-smartject
2023
false
false
false
France
French
guidelines for drug use
golimumab
pharmacovigilance note
Pre-filled Pen Syringe
injections, subcutaneous
Device malfunction
---
https://ansm.sante.fr/actualites/campagne-de-vaccination-contre-les-virus-hpv-lansm-deploie-un-dispositif-de-surveillance-renforcee
2023
false
false
false
France
French
drug information
mass vaccination
papillomavirus vaccines
france
papillomavirus infections
pharmacovigilance
product surveillance, postmarketing
papillomavirus vaccines
---
https://ansm.sante.fr/actualites/decision-dautorisation-dimportation-parallele-accordee-le-05-10-2023-triflucan-40-mg-ml-poudre-pour-suspension-buvable
2023
false
false
false
France
French
legislation
drug information
administration, oral
---
https://ansm.sante.fr/informations-de-securite/prise-en-charge-par-colchicine-de-la-goutte-une-nouvelle-posologie-plus-faible-et-un-message-dalerte-sur-les-boites-pour-reduire-le-risque-de-surdosage
2023
false
false
false
France
French
risk management
colchicine
colchicine
gout
guidelines for drug use
gout suppressants
gout suppressants
colchicine
---
https://www.cbip.be/fr/articles/4182?folia=4179
2023
false
false
false
Belgium
French
journal article
pregnancy
breast feeding
dermatitis
chronic disease
patient safety
dermatologic agents
---
https://www.has-sante.fr/jcms/p_3470393/fr/bavencio-avelumab-carcinome-a-cellules-de-merkel
2023
false
false
false
France
treatment outcome
insurance, health, reimbursement
infusions, intravenous
Antineoplastic Agents, Immunological
avelumab
evaluation of the transparency committee
carcinoma, merkel cell
avelumab
---
https://www.has-sante.fr/jcms/p_3470819/fr/cosentyx-secukinumab-hidradenite-suppuree-hs-maladie-de-verneuil
2023
false
false
false
France
treatment outcome
insurance, health, reimbursement
secukinumab
adult
injections, subcutaneous
evaluation of the transparency committee
hidradenitis suppurativa
secukinumab
---
https://ansm.sante.fr/actualites/decision-dautorisation-dimportation-parallele-accordee-le-09-11-2023-arimidex-1-mg-comprime-pellicule
2023
false
false
false
France
French
drug information
Anastrozole
france
---
https://www.has-sante.fr/jcms/p_3471700/fr/opzelura-ruxolitinib-vitiligo
2023
false
false
false
France
treatment outcome
insurance, health, reimbursement
administration, cutaneous
ruxolitinib
Janus Kinase Inhibitors
adult
adolescent
facial dermatoses
evaluation of the transparency committee
vitiligo
ruxolitinib
---
https://www.has-sante.fr/jcms/p_3471697/fr/xolair-omalizumab-urticaire-chronique-spontanee
2023
false
false
false
France
treatment outcome
insurance, health, reimbursement
anti-allergic agents
adult
adolescent
injections, subcutaneous
evaluation of the transparency committee
Chronic Urticaria
Omalizumab
Chronic Spontaneous Urticaria
---
https://www.has-sante.fr/jcms/p_3472152/fr/olumiant-baricitinib-pelade
2023
false
false
false
France
treatment outcome
insurance, health, reimbursement
administration, oral
adult
immunosuppressive agents
baricitinib
evaluation of the transparency committee
baricitinib
alopecia areata
---
https://www.has-sante.fr/jcms/p_3473151/fr/dupixent-fasenra-nucala-tezspire-et-xolair-dans-le-traitement-de-l-asthme-severe
2023
France
guidelines for drug use
No Treatment for Diabetes
Nucala
Omalizumab
Borg Category-Ratio 10 Perceived Exertion Score 5
Omalizumab
Treat
tezspire
Treatment
Treatment Study
Severe Hallucination
Intensity and Distress 5
Severe Adverse Event
During Treatment
Epidermal cGVHD Score 4
Asthma
Dupilumab
asthma
Fasenra
Asthma Pathway
xolair
severe
Severe Dysplasia
asthma, nos
On Treatment
GDC Treatment Frequency Terminology
Treatment Epoch
Therapy Object
Dupixent
asthma
Biomaterial Treatment
Severe Extremity Pain
Mepolizumab
---
http://beh.santepubliquefrance.fr/beh/2023/22-23/2023_22-23_4.html
2023
France
journal article
SEND Test System Strain
Linezolid
Vancomycin Resistant Enterococcus
france
Vancomycin-Resistant Enterococci
CHFR Gene
Evolution
Characteristic
diffuse rigidity
hospitals, proprietary
Linezolid
french
CDISC SEND Laboratory Animal Strain Terminology
vancomycin
---
https://www.has-sante.fr/jcms/p_3473772/fr/stelara-ustekinumab-psoriasis-en-plaques-rhumatisme-psoriasique-maladie-de-crohn-rectocolite-hemorragique
2023
false
false
false
France
psoriasis
adult
Interleukin Inhibitors
ustekinumab
injections, subcutaneous
Pen
evaluation of the transparency committee
Ustekinumab
colitis, ulcerative
crohn disease
arthritis, psoriatic
---
https://ansm.sante.fr/actualites/point-de-situation-sur-la-surveillance-des-vaccins-hpv
2023
false
false
false
France
French
drug information
product surveillance, postmarketing
pharmacovigilance
Vaccination Campaign
vaccination
papillomavirus vaccines
adolescent
drug monitoring
Human Papillomavirus Recombinant Vaccine nonavalent
papillomavirus (human types 6, 11, 16, 18, 31, 33, 45, 52,58)
---
https://ansm.sante.fr/disponibilites-des-produits-de-sante/medicaments/imeth-2-5-mg-et-10-mg-comprime-methotrexate
2023
false
false
false
France
French
methotrexate
administration, oral
drug information
---
https://www.inrs.fr/media.html?refINRS=TM%2079
2023
France
journal article
judgment
Usually Need Help from Another Person for Arising
chemical element, nos
Study Element
Occupational Medicine
Neither Agree or Disagree
decreased motivation
occupational health physicians
certification
Element
disease, nos
Recognition
C-C Motif Chemokine 19
motivation
spinal stenosis
Disease or Disorder
occupation, nos
Key
motivation, nos
Motivation
gait, nos
elements
occupational medicine
CCL19 wt Allele
lupus erythematosus, cutaneous
Goes Out
gait
occupational diseases
---
https://www.has-sante.fr/jcms/p_3479044/fr/sotyktu-deucravacitinib-psoriasis-en-plaques
2023
false
false
false
France
administration, oral
treatment outcome
insurance, health, reimbursement
Janus Kinase Inhibitors
deucravacitinib
adult
evaluation of the transparency committee
deucravacitinib
psoriasis
---
https://www.has-sante.fr/jcms/p_3481907/fr/xydalba-dalbavancine-infections-bacteriennes-aigues-de-la-peau-et-des-tissus-mous-ibaptm
2023
false
false
false
France
insurance, health, reimbursement
treatment outcome
skin diseases, bacterial
acute disease
soft tissue infections
adult
dalbavancin
staphylococcal skin infections
anti-bacterial agents
infusions, intravenous
evaluation of the transparency committee
dalbavancin
---
https://www.has-sante.fr/jcms/p_3486036/fr/evaluation-du-test-salivaire-endotest-dans-les-situations-complexes-de-diagnostic-d-endometriose
2023
France
health technology assessment
evaluation studies as topic
Endometriosis
diagnosis
endometriosis, nos
Assessment
Complex
Test Dosing Unit
Laboratory Procedure
Date of Diagnosis
Evaluation
endometriosis
Test Name
Diagnosis Code
no diagnosis
dermatomyositis
Physical Examination
Diagnosis Study
Blood Products Laboratory Testing
Assessment
---
https://dumas.ccsd.cnrs.fr/dumas-04394005
2023
France
dissertations, academic
dermatology
intestinal diseases
Pathology
microbiota
Intestinal Flora
Gastrointestinal Microbiome
Dermatologists
intestines
intestinal tract, nos
counseling
Dermatologist
Integumentary System Finding
Transjugular Intrahepatic Portosystemic Shunt
Diseased
---
https://www.has-sante.fr/jcms/p_3402381/fr/humira-adalimumab-maladie-de-crohn-chez-les-adolescents-et-enfants-6-ans
2023
false
false
false
France
treatment outcome
insurance, health, reimbursement
adalimumab
injections, subcutaneous
evaluation of the transparency committee
crohn disease
Adalimumab
child
adolescent
---
https://ansm.sante.fr/actualites/decision-du-17-01-2023-renouvellement-du-cpc-de-remicade-100-mg-poudre-pour-solution-a-diluer-pour-perfusion-et-des-specialites-identifiees-comme-biologiques-similaires
https://ansm.sante.fr/tableau-acces-derogatoire/remicade-et-lensemble-des-specialites-biologiques-similaires-dinfliximab
2023
false
false
false
France
French
legislation
Infliximab
takayasu arteritis
---
https://www.santepubliquefrance.fr/presse/2023/face-a-la-circulation-active-de-virus-grippaux-la-campagne-de-vaccination-contre-la-grippe-saisonniere-est-prolongee-jusqu-au-28-fevrier-2023
2023
France
popular works
influenza vaccination
influenza, human
Vaccins
activir
vaccinia virus
influenza vaccines
long
mass vaccination
face
Viruses
influenza
vaccinia virus
Influenza
preventive immunization/medication
vaccination
virus activation
Vaccinia
Virus
---
https://www.has-sante.fr/jcms/p_3407525/fr/enbrel-etanercept-immunosuppresseur
2023
false
false
false
France
insurance, health, reimbursement
evaluation of the transparency committee
immunosuppressive agents
Etanercept
---
https://www.ameli.fr/assure/sante/themes/erytheme-fessier-du-nourisson-fesses-rouges
2023
France
popular works
buttocks
erythema
diaper rash
diaper rash
Napkin dermatitis
erythema
---
https://www.ema.europa.eu/en/medicines/human/EPAR/spevigo
2023
false
false
false
Netherlands
French
English
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
spesolimab
spesolimab
spesolimab
psoriasis
Generalized pustular psoriasis
interleukin-36 receptor, human
adult
infusions, intravenous
product surveillance, postmarketing
aged
pregnancy
breast feeding
drug evaluation, preclinical
drug approval
europe
---
https://ansm.sante.fr/actualites/arret-de-commercialisation-du-medicament-josacine-josamycine
2023
false
false
false
France
French
josamycin
drug recalls
drug information
summary of product characteristics
package leaflet
---
https://www.cochrane.org/fr/CD012974/SKIN_quels-sont-les-benefices-et-les-risques-du-traitement-neoadjuvant-traitement-medicamenteux-avant
2023
United Kingdom
review of literature
french abstract
kidnapping
risks and benefits
skin neoplasms
Tumors
malignant neoplasm of skin
neoplasms
Skin cancer
Tumors
Tumors
cancer of skin
Tumors
drug therapy
neoplasm, malignant
Tumors
Tumors
operative procedure, nos
Tumors
Tumors
Tumors
Tumors
Tumors
procedural approach, nos
surgical procedures, operative
drug, nos
Melanoma
crime
Tumors
risk assessment
melanoma
melanoma, cutaneous malignant
neoadjuvant therapy
---
https://ansm.sante.fr/actualites/risque-de-meningiome-et-progestatifs-recommandations-generales-pour-limiter-ce-risque
2023
false
false
false
France
French
guidelines for drug use
meningioma
progestins
Drug-Related side effects and adverse reactions
risk management
administration, oral
meningioma
---
https://sesstim.univ-amu.fr/fr/video-box/seminaire-interne-nathalie-graffeo
2023
France
audiovisual aids
with distribution
population groups
dermatomyositis
survival
marketing
---
https://www.canada.ca/fr/sante-publique/services/rapports-publications/releve-maladies-transmissibles-canada-rmtc/numero-mensuel/2023-49/numero-2-3-fevrier-mars-2023/surveillance-sentinelle-surpasse-basee-risque-suivre-maladies-transmises-tiques.html
2023
Canada
journal article
canada
Diseases
Emerging disease
tick-borne diseases
sentinel surveillance
watchful waiting
risk
disease, nos
activir
Tick-borne disease
---
https://www.has-sante.fr/jcms/p_3421374/fr/tavneos-avacopan
2023
false
false
false
France
insurance, health, reimbursement
adult
avacopan
drug therapy, combination
Granulomatosis with Polyangiitis
microscopic polyangiitis
Rituximab
cyclophosphamide
treatment outcome
evaluation of the transparency committee
avacopan
---
https://ansm.sante.fr/tableau-marr/caplacizumab
2023
false
false
false
France
French
popular works
risk management
continuity of patient care
hemorrhage
caplacizumab
caplacizumab
---
https://www.has-sante.fr/jcms/p_3422860/fr/bimzelx-bimekizumab-psoriasis-en-plaques
2023
false
false
false
France
bimekizumab
treatment outcome
insurance, health, reimbursement
adult
injections, subcutaneous
evaluation of the transparency committee
bimekizumab
psoriasis
---
https://www.inspq.qc.ca/publications/3297-surveillance-securite-trois-premieres-doses-vaccin-covid-19
2023
Canada
technical report
COVID-19
vaccinia
vaccines
vaccine, nos
vaccination
watchful waiting
Safety
activir
COVID-19 Vaccines
Vaccinia
preventive immunization/medication
vaccination
safety
quebec
Vaccins
---
https://ansm.sante.fr/tableau-marr/baricitinib
2023
false
false
false
France
French
risk management
guidelines for drug use
patient education handout
baricitinib
baricitinib
continuity of patient care
Janus Kinase Inhibitors
Drug-Related side effects and adverse reactions
Janus Kinase Inhibitors
baricitinib
---
https://www.ema.europa.eu/en/medicines/human/EPAR/sotyktu
2023
false
false
false
Netherlands
French
English
drug approval
deucravacitinib
deucravacitinib
treatment outcome
syndication feed
summary of product characteristics
package leaflet
drug evaluation
europe
adult
psoriasis
administration, oral
dermatologic agents
dermatologic agents
Janus Kinase Inhibitors
Janus Kinase Inhibitors
TYK2 kinase
deucravacitinib
product surveillance, postmarketing
continuity of patient care
pregnancy
breast feeding
drug interactions
drug evaluation, preclinical
---
https://ansm.sante.fr/actualites/les-enfants-exposes-a-lhydroxychloroquine-pendant-la-grossesse-de-leur-mere-courent-un-risque-plus-eleve-de-malformation-grave-a-la-naissance
2023
false
false
false
France
French
abnormalities, drug-induced
teratogens
pharmacovigilance note
pregnancy
hydroxychloroquine
risk
patient education handout
In Utero Drug Exposure
antirheumatic agents
---
https://www.has-sante.fr/jcms/p_3418328/fr/e-mag-active
2023
France
health technology assessment
orthotic devices
all extremities
Joints
activir
electron
lower extremity
automatism
electronics
Electronics
robot
knee joint
automatism
activator appliances
---